HealthcareServices

Pruritus Therapeutic Market Size and Demand Forecast 2026–2030

March 2, 2026March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pruritus therapeutic market from 2026–2035 with trusted insights from The Business Research Company

How is the Pruritus Therapeutic Market size predicted to change over the forecast window of 2026–2035?

The pruritus therapeutic market has experienced robust growth in recent years. It is projected to increase from $15.38 billion in 2025 to $16.76 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.0%. The expansion observed in prior periods can be attributed to the rising incidence of dermatological and systemic conditions, more widespread adoption of antihistamines and corticosteroids, the proliferation of outpatient dermatology services, increasing patient understanding of itch-related disorders, and the availability of numerous therapeutic choices.

The pruritus therapeutic market is poised for significant expansion in the coming years. Its valuation is projected to reach $24.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period is propelled by factors such as increased investment in innovative itch-modulating treatments, a heightened emphasis on individualized pruritus care, the broadening of pipelines for biologic and immunomodulatory drugs, an escalating need for non-steroidal therapeutic options, and intensified clinical research endeavors. Key trends anticipated during this period encompass the accelerated development of targeted antipruritic medications, a growing preference for combination drug regimens, a concentrated effort on managing pruritus specific to certain diseases, the proliferation of advanced topical delivery systems, and a strengthened commitment to providing sustained symptom relief.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

Which Drivers Are Contributing To The Expansion Of The Pruritus Therapeutic Market?

The rising occurrence of chronic kidney disease is anticipated to drive expansion in the pruritus therapeutic market in the foreseeable future. Chronic Kidney Disease (CKD) is a prolonged condition characterized by a gradual decline in proper kidney function, categorized into five levels of severity. Pruritus, commonly referred to as itching, frequently manifests as a symptom of chronic kidney disease (CKD). While the precise mechanisms remain unclear, pruritus in CKD can stem from numerous causes. As an illustration, data from Kidney Research UK, a charitable organization in the UK focused on enhancing the understanding, prevention, and treatment of kidney diseases through research and advocacy, indicated that in June 2023, approximately 7.19 million individuals in the UK suffered from chronic kidney disease in 2023, accounting for over 10% of the UK population. This figure is forecast to rise to 7.61 million people by 2033. Consequently, the escalating prevalence of chronic kidney disease is fueling the pruritus therapeutic market.

What Segment Classifications Make Up The Pruritus Therapeutic Market?

The pruritus therapeutic market covered in this report is segmented –

1) By Type: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Others Types

2) By Disease Type: Atopic Dermatitis Or Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types

3) By Application: External Use, Oral, Injection

4) By End Use: Hospitals, Clinics, Other Uses

Subsegments:

1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids

2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines

3) By Local Anesthetics: Topical Local Anesthetics, Injectable Local Anesthetics

4) By Counterirritants: Menthol-Based Products, Camphor-Based Products

5) By Immunosuppressants: Systemic Immunosuppressants, Topical Immunosuppressants

6) By Calcineurin Inhibitors: Tacrolimus, Pimecrolimus

7) By Other Types: Antidepressants, Phototherapy Treatments, Biologic And Targeted Therapies

What Industry Trends Are Transforming The Pruritus Therapeutic Market?

Leading companies operating within the pruritus therapeutic market are adopting a strategic partnership model focused on treating moderate-to-severe atopic dermatitis. Strategic partnerships are defined as a process where companies utilize each other’s strengths and resources to achieve mutual advantages and successful outcomes. For example, in January 2023, Amgen Inc., a biopharmaceutical firm from the US, in collaboration with Kyowa Kirin, began investigating rocatinlimab (AMG 451/KHK4083). This compound is a potential first-in-class anti-OX40 monoclonal antibody currently being studied for patients with moderate to severe atopic dermatitis. Amgen and Kyowa Kirin have just started enrolling individuals for a global Phase 3 trial (ROCKET) to assess the safety and effectiveness of rocatinlimab in a diverse population of moderate-to-severe atopic dermatitis patients experiencing a high disease burden. The ROCKET Phase 3 program includes seven worldwide investigations. Kyowa Kirin Co., Ltd. is a pharmaceutical and biotechnology company based in Japan.

Which Leading Companies Dominate The Pruritus Therapeutic Market Share?

Major companies operating in the pruritus therapeutic market are Astellas Pharma Inc., Bristol Myers Squibb Company, Cipla Inc., Eli Lilly And Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck And Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Huapont Life Sciences Co. Ltd., LEO Pharma AS, MC2 Therapeutics Ltd., Novan Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

How Does The Pruritus Therapeutic Market Perform Across Major Global Regions?

North America was the largest region in the pruritus therapeutic market in 2025. The regions covered in the pruritus therapeutic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pruritus Therapeutic Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9925&type=smp

Browse Through More Reports Similar to the Global Pruritus Therapeutic Market 2026, By The Business Research Company

Infectious Disease Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/infectious-disease-therapeutics-global-market-report

Pruritus Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pruritus-therapeutics-global-market-report

Pertussis Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/pertussis-vaccine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795